Trial intelligence / Profile preview

Umbilical Cord Mesenchymal Stem Cells for Refractory Lupus Nephritis

NCT06485648Phase 1Not yet recruiting

Sponsor: Chinese PLA General Hospital
Start: Oct 2024
Primary completion: Oct 2026
Modality: Stem Cell Therapies

Overview

Phase 1, randomised, single-blind trial in lupus nephritis (LN) comparing uc-MSCs Group with Placebo Group (2 arms). Primary endpoints: Complete response rate, Partial response rate and 1 more. Planned start Oct 2024; status: not yet recruiting.

Drugs

human umbilical cord mesenchymal stem cells

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on NCT06485648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06485648.